419 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B N/A
Article Searches
Quincy Jones kicks off jazz concert series celebrating summer of ‘Black Power’ http://www.latimes.com/entertainment/music/la-et-ms-quincy-jones-black-power-broad-museum-soul-nation-20190530-story.html May 30, 2019 -

A viewer can’t stroll more than a few steps at the Broad Museum’s current exhibition “Soul of a Nation: Art in the Age of Black Power 1963-1983” without encountering a painting, photo or sculpture that doesn’t include an image of, or allusion to, music.

Take L.A. assemblage specialist Betye Saar’s...

Resonance Records to Stream Its Trove of Historical Jazz Albums https://www.nytimes.com/2019/05/30/arts/music/resonance-records-streaming.html?emc=rss&partner=rss May 30, 2019 - Now in its 10th year, a label that has relied on CD and vinyl sales is putting its catalog on Apple Music, Spotify and other services.
Zacks.com featured highlights include: Gilead, Jazz, Amdocs, Arch Capital and Legg Mason http://www.zacks.com/stock/news/420566/zackscom-featured-highlights-include-gilead-jazz-amdocs-arch-capital-and-legg-mason?cid=CS-ZC-FT-420566 May 28, 2019 - Zacks.com featured highlights include: Gilead, Jazz, Amdocs, Arch Capital and Legg Mason
Is Jazz (JAZZ) a Solid Growth Stock? 3 Reasons to Think " Yes " http://www.zacks.com/stock/news/420028/is-jazz-jazz-a-solid-growth-stock-3-reasons-to-think-yes-?cid=CS-ZC-FT-420028 May 27, 2019 - Jazz (JAZZ) is well positioned to outperform the market, as it exhibits above-average growth in financials.
5 Best PEG Stocks Suitable for GARP Investors http://www.zacks.com/stock/news/418985/5-best-peg-stocks-suitable-for-garp-investors?cid=CS-ZC-FT-418985 May 24, 2019 - While P/E alone only gives an idea of stocks that are trading at a discount, PEG, while adding the growth element to it, helps to identify stocks that have solid potential.
Segerstrom Center for the Arts announces its free Summer Jazz Series https://www.ocregister.com/2019/05/23/segerstrom-center-for-the-arts-announces-its-free-summer-jazz-series/ May 23, 2019 - Segerstrom Center for the Arts in Costa Mesa has announced its 2nd Annual Summer Jazz Series of free concerts, which will be held in its outdoor Julianne and George Argyros Plaza. Every Friday night June 7-Aug. 30 from 7-9 p.m., guests can show up for a free evening of a variety of styles of jazz […]
JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/416789/jazz-vs-pcrx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-416789 May 20, 2019 - JAZZ vs. PCRX: Which Stock Is the Better Value Option?
Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? http://www.zacks.com/stock/news/415565/is-jazz-pharmaceuticals-jazz-stock-undervalued-right-now?cid=CS-ZC-FT-415565 May 17, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jazz Pharmaceuticals (JAZZ) Investor Presentation - Slideshow https://seekingalpha.com/article/4262638-jazz-pharmaceuticals-jazz-investor-presentation-slideshow?source=feed_sector_healthcare May 10, 2019 - The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with this event.
3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates http://www.zacks.com/stock/news/412663/3-small-drug-stocks-poised-to-beat-q1-earnings-estimates?cid=CS-ZC-FT-412663 May 10, 2019 - So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.

Pages: 1234567...42

<Page 2>